Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
De Novo Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
De Novo Ventures

De Novo Ventures

Inactive

De Novo Ventures LLC: A venture capital firm specializing in the growth of US healthcare, medical device, and biotech companies.

Location
Saratoga, CA, US
Founded
2003
Firm
Compare
Portfolio
Employees

De Novo Ventures LLC operates as a venture capital firm. The Company focuses on all stages of enterprise development and growth.

De Novo primarily targets healthcare companies with a focus on medical device and biotechnology companies in the United States.

De Novo Ventures - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments52
Current Portfolio Count15
Total Portfolio Exits5

Top Investment Stages

Series B16 (37.2%)
Series C9 (20.9%)
Series A7 (16.3%)
Series Unknown6 (14.0%)
Series D5 (11.6%)

Stage Mix

Series B 37%Series C 21%Series A 16%Series Unknown 14%Series D 12%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Milo logo

Milo

Benvenue Medical logo

Benvenue Medical

EndoGastric Solutions logo

EndoGastric Solutions

Tria Beauty logo

Tria Beauty

Astute Medical logo

Astute Medical

Viracta Therapeutics logo

Viracta Therapeutics

Pulmonx logo

Pulmonx

Simpirica Spine logo

Simpirica Spine

Spiracur logo

Spiracur

Articulinx logo

Articulinx

PhotoThera logo

PhotoThera

Synergeyes logo

Synergeyes

Sierra Surgical logo

Sierra Surgical

Point Biomedical logo

Point Biomedical

Axogen logo

Axogen

Vitreoretinal Technologies logo

Vitreoretinal Technologies

Paracor Medical logo

Paracor Medical

Talima Therapeutics logo

Talima Therapeutics

Ovalis logo

Ovalis

Bayhill Therapeutics logo

Bayhill Therapeutics

Iscience Surgical logo

Iscience Surgical

De Novo Ventures - Similar Investment Firms

Devon Park Bioventures logo

Devon Park Bioventures

Novit Ventures logo

Novit Ventures

novitventures.com

Novel Bioventures logo

Novel Bioventures

Denali Ventures logo

Denali Ventures

Novus Ventures logo

Novus Ventures

novus-ventures.com

30Ventures logo

30Ventures

Bioventures Investors logo

Bioventures Investors

Vye Ventures logo

Vye Ventures

Mayo Clinic Ventures logo

Mayo Clinic Ventures

Noemis Ventures logo

Noemis Ventures

Noventi logo

Noventi

noventi.net

McKesson Ventures logo

McKesson Ventures

NewDo Venture logo

NewDo Venture

newdoventure.com

MedVenture Associates logo

MedVenture Associates

EDF Ventures logo

EDF Ventures

De Novo Ventures - Classification

Also Known As
  • De Novo Ventures, LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end